• bitcoinBitcoin(BTC)$77,216.00-1.64%
  • ethereumEthereum(ETH)$2,467.61-0.55%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$716.46-0.91%
  • rippleXRP(XRP)$1.35-3.03%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$99.85-2.16%
  • tronTRON(TRX)$0.338901-0.45%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.040.87%
  • zcashZcash(ZEC)$1,096.83-11.29%
  • HyperliquidHyperliquid(HYPE)$79.82-4.95%
  • dogecoinDogecoin(DOGE)$0.084084-2.23%
  • RainRain(RAIN)$0.015753-3.76%
  • USDSUSDS(USDS)$1.00-0.01%
  • moneroMonero(XMR)$513.87-0.42%
  • whitebitWhiteBIT Coin(WBT)$79.93-1.35%
  • chainlinkChainlink(LINK)$11.58-2.43%
  • leo-tokenLEO Token(LEO)$9.10-1.04%
  • cardanoCardano(ADA)$0.209688-2.15%
  • stellarStellar(XLM)$0.176202-2.63%
  • daiDai(DAI)$1.000.01%
  • bitcoin-cashBitcoin Cash(BCH)$227.33-9.52%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • USD1USD1(USD1)$1.000.02%
  • litecoinLitecoin(LTC)$52.890.08%
  • CantonCanton(CC)$0.098527-5.30%
  • uniswapUniswap(UNI)$6.161.02%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.36-1.42%
  • hedera-hashgraphHedera(HBAR)$0.075486-2.10%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • avalanche-2Avalanche(AVAX)$7.52-4.28%
  • nearNEAR Protocol(NEAR)$2.47-1.16%
  • suiSui(SUI)$0.74-3.98%
  • shiba-inuShiba Inu(SHIB)$0.000005-2.66%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • crypto-com-chainCronos(CRO)$0.056554-2.47%
  • tether-goldTether Gold(XAUT)$4,345.61-1.74%
  • MemeCoreMemeCore(M)$1.17-4.70%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • okbOKB(OKB)$110.24-2.78%
  • BittensorBittensor(TAO)$237.12-7.14%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.140.07%
  • polkadotPolkadot(DOT)$1.153.69%
  • AsterAster(ASTER)$0.71-2.54%
  • mantleMantle(MNT)$0.58-3.55%
  • aaveAave(AAVE)$123.43-1.53%
  • pax-goldPAX Gold(PAXG)$4,350.92-1.72%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.056101-1.41%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Anthropic Caught Scientists Using Claude To Further Biological Weapon Research

September 10, 2026
in AI & Technology
Reading Time: 3 mins read
A A
Anthropic Caught Scientists Using Claude To Further Biological Weapon Research
ShareShareShareShareShare

The company has produced an extensive collection of case studies covering the ways its current AI models have been misused.



Michael M. Santiago/Getty Images

Anthropic has flagged and stopped multiple scientists who were using its AI models to create potential biological weapons, according to a new report the company shared on Thursday. “Biological misuse” is just one flavor of troubling AI usage the report documents, but it’s of growing importance because newer models like Fable 5 are increasingly good at helping with scientific research.

YOU MAY ALSO LIKE

How These XL Phones Compete

CA Governor Signs ‘Landmark’ Laws On Youth Use Of Social Media And AI Chatbots

The company’s report includes five case studies of Anthropic’s models being used to develop biological weapons, the safety measures that brought the misuse to Anthropic’s attention and how it responded. Detecting possible misuse is complicated, as the company stressed to The New York Times, because research into a new vaccine could look a lot like creating a bioweapon. In all cases the company says it erred on the side of being overly cautious because of the possible consequences.

“You are not seeing someone in a comic book kind of way say, ‘Hey, I want to build a biological weapon to kill everybody,'” Jacob Klein, Anthropic’s head of threat intelligence, told The New York Times. “It’s an incredibly nuanced situation.”

In one case study from May, Anthropic says its “biological safety classifier” flagged a request for Claude to author a grant for gain-of-function research on chikungunya virus. The virus has no licensed treatment and can cause debilitating symptoms for weeks or months, the company says. Gain-of-function research explores methods for genetically altering an organism, and in the case of this specific virus, the grant proposed increasing its transmissibility and ability to evade immune response. The combination sounds dangerous, and Anthropic says the fact that the proposed research was affiliated with a military research institute made it extra questionable.

The company took similar issue with gain-of-function research into bird flu and a separate case of a researcher using Claude to develop an atlas of venom toxin peptides and “a generative pipeline that optimized toxin characteristics.” The full report also includes case studies on Anthropic’s models being used as a surveillance tool and to create software exploits, propaganda and weapons systems.

According to the company, anyone misusing Claude or Anthropic models had their account banned, and the findings from the investigation are being used to further improve model safeguards and prevent future misuse. Given the tricky nature of biological misuse, Anthropic is also not naming the individuals or institutions its investigation connected to the development of possible biological weapons. “The individuals implicated in these case studies are working scientists,” Anthropic says. “We do not assert that they intended harm, and identifying them or their labs could expose them to harm.”

Credit: Source link

ShareTweetSendSharePin

Related Posts

How These XL Phones Compete
AI & Technology

How These XL Phones Compete

September 10, 2026
CA Governor Signs ‘Landmark’ Laws On Youth Use Of Social Media And AI Chatbots
AI & Technology

CA Governor Signs ‘Landmark’ Laws On Youth Use Of Social Media And AI Chatbots

September 10, 2026
Meet Redis LangCache: A Managed Semantic Cache That Cuts LLM API Costs by Up to 90% and Returns Cache Hits Up to 15x Faster
AI & Technology

Meet Redis LangCache: A Managed Semantic Cache That Cuts LLM API Costs by Up to 90% and Returns Cache Hits Up to 15x Faster

September 10, 2026
NVIDIA Details BioNeMo Inference Runtime (BioIR): 2.90x Higher Boltz-2 Folding Throughput and 58.5K Residues per GPU-Hour on 8xH100
AI & Technology

NVIDIA Details BioNeMo Inference Runtime (BioIR): 2.90x Higher Boltz-2 Folding Throughput and 58.5K Residues per GPU-Hour on 8xH100

September 10, 2026
Next Post
Seattle business leaders call on mayor to tackle public safety crisis

Seattle business leaders call on mayor to tackle public safety crisis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Mounting frustrations over Wisconsin police shooting

Mounting frustrations over Wisconsin police shooting

September 6, 2026
Everything Announced During Nintendo Direct

Everything Announced During Nintendo Direct

September 9, 2026
Rigetti: If You Wanted To Buy Quantum, Do It Now

Rigetti: If You Wanted To Buy Quantum, Do It Now

September 10, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!